Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis.
Marta Sidoryk-WęgrzynowiczLidia StrużyńskaPublished in: International journal of molecular sciences (2021)
Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system that leads to the progressive disability of patients. A characteristic feature of the disease is the presence of focal demyelinating lesions accompanied by an inflammatory reaction. Interactions between autoreactive immune cells and glia cells are considered as a central mechanism underlying the pathology of MS. A glia-mediated inflammatory reaction followed by overproduction of free radicals and generation of glutamate-induced excitotoxicity promotes oligodendrocyte injury, contributing to demyelination and subsequent neurodegeneration. Activation of purinergic signaling, in particular P2X7 receptor-mediated signaling, in astrocytes and microglia is an important causative factor in these pathological processes. This review discusses the role of astroglial and microglial cells, and in particular glial P2X7 receptors, in inducing MS-related neuroinflammatory events, highlighting the importance of P2X7R-mediated molecular pathways in MS pathology and identifying these receptors as a potential therapeutic target.
Keyphrases
- multiple sclerosis
- induced apoptosis
- neuropathic pain
- white matter
- oxidative stress
- inflammatory response
- cell cycle arrest
- lipopolysaccharide induced
- lps induced
- end stage renal disease
- mass spectrometry
- ejection fraction
- newly diagnosed
- endoplasmic reticulum stress
- machine learning
- ms ms
- cell death
- chronic kidney disease
- diabetic rats
- traumatic brain injury
- spinal cord injury
- deep learning
- cell proliferation
- human health
- brain injury
- stress induced
- cerebral ischemia